A pink alarm clock, a blue surgical mask, a syringe, and two vials lie on a blue surface, indicating how the time of cancer immunotherapy administration may influence their outcomes.
| 2 min read
People with cancer receiving immunotherapy earlier in the day survived longer, suggesting that adjusting treatment timing may improve outcomes.

immune checkpoint blocker

A doctor in a white coat with a stethoscope holds a futuristic transparent screen displaying a digital interface with AI-powered health diagnostics.

An AI-Based Model Could Predict Cancer Immunotherapy Outcomes

Engineered Bacteria Make Tumors More T Cell-Friendly

Engineered Bacteria Make Tumors More T Cell-Friendly

 Improving sensitivity and reproducibility with automated western assays

Uncovering the Cancer Proteome with Automated Western Assays

fingertips with pills on them

Over-the-Counter Antihistamines Could Help Against Cancer

Understand Mechanisms of Cancer Evasion with Multiomic CRISPR Screens

Multiomic Single Cell CRISPR Screens Reveal Cancer Evasion Mechanisms

car t cell infographic april 2019 the scientist solid tumor liquid cancer

Infographic: CAR-T Cells in Solid Versus Liquid Cancers

More Cancer Mutations, Better Immunotherapy Outcomes

Fecal Transplant Heals Colitis Caused by Immunotherapy

Opinion: Learning from Immunotherapy’s Recent Failures

Trending

Kirsty Wright is searching for evidence in a missing persons investigation. She is wearing a blue shirt and glasses. Behind her is dense vegetation and police procedural tape.

How a Forensic Biologist Exposed a DNA Lab Scandal That Shook Australia

Photo of John Calhoun crouches within his rodent utopia-turned-dystopia

Universe 25 Experiment

Hands holding an older woman’s hands.

One Gene Influences 75 Percent of Alzheimer’s Disease Cases

A picture of Rohita Roy, a postdoc at Stanford University.

Postdoc Portrait: Rohita Roy

Multimedia

The Scientist Placeholder Image

From Data to Discovery: Omics in Therapeutic Innovation

The Scientist Placeholder Image

Exploring Organoids for Disease Modeling Research

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies